Home
Conditions
Multiple Myeloma and Plasma Cell Neoplasm

Clinical trial condition

Multiple Myeloma and Plasma Cell Neoplasm

Explore clinical trials studying Multiple Myeloma and Plasma Cell Neoplasm. Study availability and eligibility vary by location and protocol.

214 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma and Plasma Cell Neoplasm trial results

Completed

S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease

NCT00898066

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +25 more
Locations: Not specified

View Trial Details

Completed

PAD. ICORG 05-01, V11

NCT00814541

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital Dublin, Ireland

Mater Misericordiae University Hospital Dublin, Ireland

St. James's Hospital Dublin, Ireland

University College Hospital Galway, Ireland

View Trial Details

Completed

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

NCT00004258

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +83 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

NCT00589563

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +70 more
Locations: Banner Good Samaritan Medical Center Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +116 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

NCT00003572

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +46 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00003960

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

Center for Cancer Treatment and Research Columbia, South Carolina, United States

View Trial Details

Completed

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00003962

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +50 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00265837

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00033332

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States

Stanford University Medical Center Stanford, California, United States

View all 78 locations

View Trial Details

Multiple Myeloma and Plasma Cell Neoplasm

Multiple Myeloma and Plasma Cell Neoplasm trial results

Related conditions